{"id":385858,"date":"2022-12-22T00:00:00","date_gmt":"2022-12-22T00:00:00","guid":{"rendered":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037420-medtech-vascular-access-devices-market-insights-us-2023\/"},"modified":"2026-03-31T10:13:16","modified_gmt":"2026-03-31T10:13:16","slug":"47037420-medtech-vascular-access-devices-market-insights-us-2023","status":"publish","type":"report","link":"https:\/\/clarivate.com\/life-sciences-healthcare\/report\/47037420-medtech-vascular-access-devices-market-insights-us-2023\/","title":{"rendered":"Vascular Access Devices | Market Insights | US | 2023"},"content":{"rendered":"<p>The US vascular access device market is well-established and will grow marginally over the forecast period. Unit sales will be supported by steady growth in the underlying patient population undergoing medical procedures that require vascular access; however, the maturity of the vascular access device market has resulted in strong downward pressures on\u00a0ASPs that will somewhat inhibit revenue expansion. Additionally, changes in the standard-of-practice will continue to drive a shift away from the use of\u00a0PICCs to midline catheters, which will further restrict growth in aggregate\u00a0ASPs given that midline catheters are less expensive than\u00a0PICCs. Importantly, vascular access devices represent a key component of care in\u00a0COVID-19\u00a0treatments; therefore, the pandemic has had both positive and negative impact on procedure and unit volumes in the vascular access device space.<\/p>\n<p>This Medtech 360 Report provides comprehensive data and analysis on the state of the market for vascular access devices in the US from 2019 through 2031.<\/p>\n","protected":false},"template":"","class_list":["post-385858","report","type-report","status-publish","hentry","report-gateway-medtech","medtech-therapy-area-vascular-access-devices","medtech-date-967"],"acf":[],"publishpress_future_workflow_manual_trigger":{"enabledWorkflows":[]},"_links":{"self":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385858","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report"}],"about":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/types\/report"}],"version-history":[{"count":1,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385858\/revisions"}],"predecessor-version":[{"id":387368,"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/report\/385858\/revisions\/387368"}],"wp:attachment":[{"href":"https:\/\/clarivate.com\/life-sciences-healthcare\/wp-json\/wp\/v2\/media?parent=385858"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}